Revolution Medicines, Inc.
RVMD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001628171
In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 17 sales; 693 institutions reported holding it in 13F filings for Q2 2026, worth $40.1B in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesRVMDW
13F holders, Q2 2023
Institutional positions in Revolution Medicines, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 139
- −12 vs. Q1 2023
- Shares held
- 112.0M
- +3.74M (+3.5%) vs. Q1 2023
- Total value
- $2.99B
- +$651.4M (+27.8%) vs. Q1 2023
- New holders
- 12
- 57 more added
- Sold out
- 24
- 42 more reduced
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 693 | $40.1B |
| Q1 2026 | 514 | $19.1B |
| Q4 2025 | 387 | $15.9B |
| Q3 2025 | 323 | $8.96B |
| Q2 2025 | 308 | $7.02B |
| Q1 2025 | 284 | $6.83B |
| Q4 2024 | 281 | $8.45B |
| Q3 2024 | 255 | $7.74B |
| Q2 2024 | 223 | $6.54B |
| Q1 2024 | 210 | $5.18B |
| Q4 2023 | 184 | $4.59B |
| Q3 2023 | 168 | $3.11B |
| Q2 2023 | 139 | $2.99B |
| Q1 2023 | 152 | $2.34B |
| Q4 2022 | 135 | $2.10B |
| Q3 2022 | 142 | $1.74B |
| Q2 2022 | 135 | $1.49B |
| Q1 2022 | 126 | $1.89B |
| Q4 2021 | 117 | $1.85B |
| Q3 2021 | 114 | $1.99B |
| Q2 2021 | 130 | $2.23B |
| Q1 2021 | 128 | $3.05B |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Revolution Medicines, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Norges Bank | 367,487 | $9.83M | 0.00% | −146,529−28.5% | Reduced |
| Millennium Management LLC | 374,090 | $10.0M | 0.01% | −178,961−32.4% | Reduced |
| Bank of New York Mellon Corp | 411,541 | $11.0M | 0.00% | +118,930+40.6% | Added |
| Bessemer Group Inc | 442,442 | $11.8M | 0.03% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 443,574 | $11.9M | 0.02% | +246,741+125.4% | Added |
| DAFNA Capital Management LLC | 512,285 | $13.7M | 3.75% | −63,500−11.0% | Reduced |
| Sofinnova Investments, Inc. | 520,377 | $13.9M | 0.92% | +336,539+183.1% | Added |
| Candriam Luxembourg S.C.A. | 579,948 | $15.5M | 0.11% | −26,384−4.4% | Reduced |
| FMR LLC | 582,712 | $15.6M | 0.00% | −15,959−2.7% | Reduced |
| Goldman Sachs Group Inc | 697,679 | $18.7M | 0.00% | −438,379−38.6% | Reduced |
| Rock Springs Capital Management LP | 702,712 | $18.8M | 0.45% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 711,111 | $19.0M | 0.01% | +53,884+8.2% | Added |
| Frazier Life Sciences Management, L.P. | 854,484 | $22.9M | 1.37% | 00.0% | Unchanged |
| Northern Trust Corp | 917,693 | $24.5M | 0.00% | +132,136+16.8% | Added |
| Morgan Stanley | 983,495 | $26.3M | 0.00% | +598,758+155.6% | Added |
| Avidity Partners Management LP | 1,075,000 | $28.8M | 1.00% | −269,800−20.1% | Reduced |
| Ameriprise Financial Inc | 1,223,725 | $32.7M | 0.01% | +99,767+8.9% | Added |
| Janus Henderson Group PLC | 1,317,842 | $35.2M | 0.02% | +965,014+273.5% | Added |
| Dimensional Fund Advisors LP | 1,668,776 | $44.6M | 0.01% | +58,789+3.7% | Added |
| Deerfield Management Company, L.P. (Series C) | 1,751,496 | $46.9M | 1.00% | +921,759+111.1% | Added |
| Casdin Capital, LLC | 1,810,000 | $48.4M | 4.23% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 1,948,460 | $52.1M | 0.01% | +214,383+12.4% | Added |
| Holocene Advisors, LP | 2,178,060 | $58.3M | 0.25% | +73,242+3.5% | Added |
| Artal Group S.A. | 2,401,617 | $64.2M | 2.06% | +330,629+16.0% | Added |
| The Column Group LLC | 2,577,220 | $68.9M | 26.76% | −2,000,620−43.7% | Reduced |
| Baker Bros. Advisors LP | 2,691,493 | $72.0M | 0.42% | 00.0% | Unchanged |
| Farallon Capital Management, L.L.C. | 2,783,480 | $74.5M | 0.45% | −500,120−15.2% | Reduced |
| Woodline Partners LP | 3,761,375 | $100.6M | 1.20% | +338,403+9.9% | Added |
| JPMorgan Chase & Co | 3,967,753 | $106.1M | 0.01% | +705,115+21.6% | Added |
| Boxer Capital, LLC | 4,684,264 | $125.3M | 5.81% | 00.0% | Unchanged |
| State Street Corp | 4,744,249 | $126.9M | 0.01% | −67,182−1.4% | Reduced |
| Bellevue Group AG | 4,746,000 | $127.0M | 1.81% | −1,9000.0% | Reduced |
| Nextech Invest AG | 4,839,529 | $129.5M | 44.00% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 5,018,765 | $134.3M | 0.02% | −16,414−0.3% | Reduced |
| BVF Inc | 6,255,588 | $167.3M | 4.66% | +1,300,000+26.2% | Added |
| EcoR1 Capital, LLC | 7,198,700 | $192.6M | 5.08% | +1,846,517+34.5% | Added |
| BlackRock Inc. | 8,257,616 | $220.9M | 0.01% | +791,842+10.6% | Added |
| Vanguard Group Inc | 9,340,503 | $249.9M | 0.01% | +37,950+0.4% | Added |
| Wellington Management Group LLP | 10,289,689 | $275.2M | 0.05% | −135,679−1.3% | Reduced |
| Mass General Brigham, Inc | 0 | $0 | 0.00% | −338,191−100.0% | Sold out |
| Harvard Management Co Inc | 0 | $0 | 0.00% | −315,550−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −162,148−100.0% | Sold out |
| Sio Capital Management, LLC | 0 | $0 | 0.00% | −125,957−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −110,414−100.0% | Sold out |
| Duality Advisers, LP | 0 | $0 | 0.00% | −73,075−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −54,627−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −43,300−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −28,700−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −28,452−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −27,033−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −26,811−100.0% | Sold out |
| Moloney Securities Asset Management, LLC | 0 | $0 | 0.00% | −11,650−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −11,156−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −2,380−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −346−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −323−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −238−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −164−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Schubert & Co | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Steward Financial Group LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Kula Investments, LLC | – | – | – | – | Not filed |